Aesthetic
+ derm.

Aesthetic marketing fails when it ignores the visual layer.

Why aesthetic marketing lives on visual platforms

Aesthetic and cosmetic dermatology patients make decisions visually. They see a before/after on Instagram, save the post, watch the provider talk about the procedure on YouTube, read 8-12 reviews on Google Maps, and book the consultation only after the visual proof and provider personality have aligned with their aspiration. A marketing programme that under-invests in visual content underperforms in this category — period.

This is one of the most concentrated examples in healthcare of channel-mix inversion: aesthetic practices that allocate <30% of marketing spend to visual social (Instagram + TikTok) consistently lose to practices that allocate 45-60%. Search-led acquisition still works for high-intent moments ("best aesthetic clinic [city]") but search captures the buying moment, not the consideration arc — and aesthetic patients spend most of their consideration arc on social.

What we ship for aesthetic engagements

The standard 12-month aesthetic programme builds: a visual social engine producing 12-20 pieces of weekly content (before/after reels, treatment process video, provider personality content, behind-the-scenes); SEO across 180+ procedure clusters with provider profile schema; influencer partnerships with verified micro-influencers (10K-100K followers in beauty/wellness) at 2-3× the LTV of generic paid traffic; a membership architecture that converts one-off patients into compounding revenue; procedure landing pages with cost transparency, financing options, compliance-cleared before/after galleries, and virtual-consult booking; and a reputation programme that maintains 4.7★+ across Google, Practo, RateMDs.

The membership layer is where aesthetic practices either compound or stagnate. A patient who books a single Botox treatment is worth ₹15-25K. The same patient on a monthly facial + quarterly laser membership is worth ₹65-95K over 12 months. Practices that don't have a membership architecture leave the majority of patient lifetime value on the table — they're optimising for the booking, not the relationship.

Compliance reality

Aesthetic advertising in India operates under tight constraints. Botox, dermal fillers, and similar are Schedule H drugs — direct advertising is prohibited. ASCI restricts before/after on cosmetic procedures unless statistically representative and consent-documented. The Drugs and Magic Remedies Act prohibits specific outcome claims for many aesthetic treatments. The US adds FDA + FTC requirements for testimonials and outcome disclosures. We use compliant capability copy that signals capability without making prohibited claims, and we pre-clear every page through the practice's medical advisor.

What good looks like in 12 months

After a full aesthetic engagement: 250-340% growth in first-treatment bookings, 50-65% reduction in cost-per-booking, 35-45% membership uptake among first-time patients (versus industry baseline of 12-18%), 12-month patient LTV of ₹65-95K (versus ₹15-25K for one-off-only practices), and a measurable shift in the practice's social audience that compounds organic reach over time.

Things aesthetic & derm teams ask us first.

10 aesthetic files, indexed.

Other industries.